Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05897528 · ClinicalTrials.gov registry record
Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection
A clinical trial, sponsored by Arrowhead Regional Medical Center.
- Completed
- Registry status
- 589
- Enrollment target
NCT05897528 is a clinical trial that has completed, run by Arrowhead Regional Medical Center. The registered enrollment target is 589 participants.
The verdict
NCT05897528 has completed, sponsored by Arrowhead Regional Medical Center.
- COMPLETED
- Registry status
- 589 participants
- Enrollment target
Study Summary
The Coronavirus Disease of 2019 (COVID-19) pandemic has caused an international healthcare crisis and produced a large healthcare burden. Diabetes mellitus is a common disease that can be controlled via pharmacologic agents; however, many patients have poor glycemic control, leading to disease-related complications. Diabetes mellitus has been reported in the literature to be associated with increasing morbidity and mortality in COVID-19 patients, and some hypothesize that this is due to insulin dysregulation propagating a pro-inflammatory state. The investigators aim to contribute to the growing body of literature that assesses the associations between glucose homeostasis and COVID-19 disease severity and mortality.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 589 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2022-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05897528
The ClinicalTrials.gov registry entry for NCT05897528 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 589 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arrowhead Regional Medical Center, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT05897528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05897528 about?
NCT05897528 is a clinical study titled "Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection". The Coronavirus Disease of 2019 (COVID-19) pandemic has caused an international healthcare crisis and produced a large healthcare burden. Diabetes mellitus is a common disease that can be controlled via pharmacologic agents; however, many patients have poor glycemic control, leading to disease-relat...
What is the current status of trial NCT05897528?
This trial is currently completed. The enrollment target is 589 participants. The study started on 2021-10-14. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT05897528?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT05897528?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.